Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy

Journal of Clinical Oncology

Volumn 20, Issue 13, 2002, Pages 3030-3032

  Dourakis, S P ^a   Sevastianos, V A ^a   Alexopoulou, A ^a   Deutsch, M ^a   Stavrianeas, N ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; DOCETAXEL; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; PACLITAXEL; TAXOID;

ADULT; ARTICLE; BLISTER; CASE REPORT; CORNEA ULCER; DESQUAMATION; DIARRHEA; ERYTHEMA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; NONHODGKIN LYMPHOMA; OROPHARYNX; PARESTHESIA; PRIORITY JOURNAL; TOXIC EPIDERMAL NECROLYSIS; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; NEUTROPENIA; SALVAGE THERAPY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ERUPTIONS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; NEUTROPENIA; PACLITAXEL; SALVAGE THERAPY; TAXOIDS; TREATMENT OUTCOME;

EID: 0036637263     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2002.20.13.3030     Document Type: Article

References (3)

1. Prospects with docetaxel in the treatment of patients with breast cancer
2. Phase II study of docetaxel for current or metastatic non-small-cell lung cancer
3. New agents in the management of non-small lung cancer